BAMCO Inc
MDGL icon

BAMCO Inc’s Madrigal Pharmaceuticals MDGL Stock Holding History

BAMCO Inc’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.42M Sell
4,500
-800
-15% -$410K ﹤0.01% 278
2026
Q1 		$2.77M Buy
5,300
+2,800
+112% +$1.34M 0.01% 272
2025
Q4 		$1.46M Sell
2,500
-100
-4% -$51.1K ﹤0.01% 290
2025
Q3 		$1.19M Buy
+2,600
New +$970K ﹤0.01% 297

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc's MDGL Position: Q2 2026 in Review

BAMCO Inc reduced its Madrigal Pharmaceuticals (MDGL) stake by 15% in Q2 2026, selling an estimated $410K and leaving 4,500 shares worth $2.42M. The position accounts for ﹤0.01% of the portfolio, ranked #278.

BAMCO Inc first reported a position in MDGL in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.77M in Q1 2026. 413 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • BAMCO Inc held 4,500 shares of Madrigal Pharmaceuticals worth $2.42M as of Q2 2026.
  • BAMCO Inc sold 800 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $410K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of BAMCO Inc's portfolio in Q2 2026, its #278 holding.
  • BAMCO Inc first reported a position in Madrigal Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • BAMCO Inc's Madrigal Pharmaceuticals position peaked at $2.77M in Q1 2026.
  • 413 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on BAMCO Inc's 13F filing for Q2 2026, filed 14 Aug 2026.